METHODOLOGY
The 2022 BDO Life Sciences CFO Outlook Survey polled 100 life sciences industry CFOs with revenues ranging from $100 million to $3 billion in October 2021. The survey was conducted by Rabin Research Company, an independent marketing research firm, using Op4G’s panel of executives.
ANNUAL REVENUE
9% |
$2B-$3B+ |
18% |
$1B-$2B |
14% |
$751M-$999M |
13% |
$501M-$700M |
8% |
$251M-$500M |
38% |
$100M-$250M |
REGIONAL OPERATIONS FOR U.S. - BASED COMPANIES
63% |
U.S. only |
28% |
Canada |
22% |
Europe |
21% |
Latin / South America |
19% |
Asia-Pacific |
4% |
Africa |
TYPES OF LIFE SCIENCES ORGANIZATION
20% |
Biopharma / Pharma |
20% |
Biotech |
20% |
Medtech |
20% |
Medical devices |
20% |
Drug manufacturers / supplies |